Mutation scanning provides the simplest, lowest-cost method for identifying DNA variations on single PCR amplicons, and it may be performed before sequencing to avoid screening of noninformative wild-type samples. High-resolution melting (HRM) is the most commonly used method for mutation scanning. With PCR-HRM, however, mutations less abundant than approximately 3%-10% that can still be clinically significant may often be missed. Therefore, enhancing HRM detection sensitivity is important for mutation scanning and its clinical application.
The discovery and detection of molecular biomarkers for gene diagnosis has become a fast-growing field in the era of precision medicine. Mutation scanning without previous knowledge of the mutation type or position is of importance because it can help screen for multiple clinically important biomarkers in target genes, as well as discover new biomarkers with potential clinical significance. Sequencing is the gold standard for mutation discovery and identification, and its cost is steadily decreasing, as efforts are made to reduce the cost of data generation and variation in data management and improve data interpretation in downstream analysis of next-generation sequencing (1) (2) (3) (4) . Nevertheless, mutation scanning provides the lowest-cost method for identifying DNA variations on single PCR amplicons, and it may be performed before sequencing to avoid screening of noninformative wild-type (WT) 4 samples when few sequences are to be investigated. Accordingly, methods such as high-resolution melting (HRM) (5, 6 ) are commonly used in clinical applications for mutation scanning (7, 8 ) . HRM is normally conducted in a post-PCR fashion and can be easily done in a routine laboratory with a real-time PCR machine. However, PCR-HRM may often miss mutations less abundant than approximately 3%-10% (9 ) that may be clinically significant, such as mutations in plasma. Therefore, increasing detection sensitivity in HRM mutation scanning can increase its clinical value.
Here we examine the influence of adding DMSO to HRM detection. DMSO is used for increasing the amplification efficiency of GC-rich sequences (10, 11 ) , because it helps open up secondary structures and weaken hydrogen bonds between base pairs (12, 13 ) . Destabilization of DNA via addition of betaine before melting analysis of real-time PCR products generates a narrower melting peak for the probe-template duplex (14 ) , whereas addition of high-salt buffer may improve clustering in HRM analysis (15 ) . Graziano et al. (16 ) demonstrated that DMSO added before melting curve analysis with the nonsaturating dye SYBR Green I increases the separation between WT and mutant amplicons. Because HRM uses saturating dyes for high sensitivity and reproducibility (17, 18 ) , we anticipated that addition of DMSO would have an even more pronounced effect than SYBR Green I on the thermodynamic difference between mutant and WT amplicons. This, in turn, could translate to an increase in the mutation detection sensitivity of HRM. Along with the addition of DMSO, we examined concomitant coamplification at lower denaturation temperature (COLD)-PCR. COLD-PCR (19, 20 ) is another way to increase HRM detection sensitivity, by providing mutation enrichment during PCR on the basis of DNA melting properties (22 ) with minimal change to existing conventional PCR workflows (23) (24) (25) (26) . Full-COLD-PCR (19, 23 ) is a COLD-PCR version able to enrich multiple mutations along a target sequence by including an extra step for crosshybridization to generate mismatched duplexes, followed by preferential denaturation and amplification at optimized critical temperature.
We report on the use of DMSO to increase the detection sensitivity of PCR-HRM and combination with full-COLD-PCR to provide a combined improvement.
Materials and Methods

CELL LINES AND CLINICAL SAMPLES
In this study, we assessed missense mutations in several positions of TP53 (tumor protein p53) 5 exon 8. Human genomic DNA from commercial cell lines SW480 (ATCC CCL-228™, p.R273H, c.818GϾA), HCC1008 (ATCC CRL-2320™, p.D281H, c.841GϾC), and PFSK-1 (ATCC CRL-2060™, p.C275G, c.823TϾG) was extracted with the DNeasy™ Blood and Tissue kit (Qiagen) following the manufacturer's protocol. We used human genomic DNA (Promega) as WT control DNA and to create mixtures of WT and mutant DNA with gradually decreasing mutation abundances. Standard reference DNA containing multiple low-abundance mutations in a variety of genes was purchased from Horizon Diagnostics.
To evaluate the utility of the present approach in characterizing samples from different origins, we analyzed whole genome-amplified DNA from 11 myelodysplastic syndrome (MDS) samples without detectable TP53 exon 8 mutation when screened via MALDI-TOF or conventional PCR coupled with Sanger sequencing (28, 29 ) . We also evaluated genomic DNA from 3 lung tumor samples (TL6, TL8, and TL121) that previously were confirmed to harbor missense mutations present at a low frequency (2%, 1%, and 1%, respectively) and a colorectal tumor sample (CT20) with a missense mutation at an abundance of approximately 1% (26, 30 ) (see Supplementary Table  1A , which accompanies the online version of this article at http://www.clinchem.org/content/vol61/issue11).
CONVENTIONAL PCR AND FULL-COLD-PCR
PCR reactions were performed on SmartCycler realtime PCR system (Cepheid) or CFX Connect™ realtime PCR (Bio-Rad Laboratories) with Phusion HighFidelity DNA polymerase (New England Biolabs) and LCGreen Plusϩ (BioFire Diagnostics) or SYBR Green I (Life Technologies) as fluorescence dyes. Primers were designed for TP53 exon 8 and 5 other genes (see online Supplementary Table 1B). We used 10 ng genomic DNA as template in a 25-L PCR mix including 1ϫ Phusion HF buffer, 200 nmol/L of each primer, 200 mol/L of each of the 4 dNTPs, 0.8ϫ LCGreen, and 0.5 U Phusion polymerase. PCR with SYBR Green I was conducted by use of a 0.1ϫ SYBR Green I dilution from an original 10 000ϫ concentration. Higher amounts of this dye during PCR cause inhibition of Phusion polymerase (not shown). For conventional PCR, an initial denaturation step was performed for 2 min at 98°C, followed by 45 cycles of 10-s denaturation at 98°C, 20-s annealing at 58°C, and 10-s elongation at 72°C. The final step included a melting curve (0.2°C increments, 2-or 4-s hold before each acquisition) from 65°C to 95°C. For full-COLD-PCR, initial optimization was conducted to establish the main factors that affect enrichment efficiency. As shown in online Supplementary Materials, programs were run to find out the optimal combination of conventional PCR cycle number n, full-COLD-PCR cycle number m, and the critical temperature (T c ) for mutant-preferential amplification. Then the program for full-COLD-PCR was set with an initial denaturation step at 98°C for 2 min, followed by n cycles of conventional PCR cycling (98°C, 10 s; 58°C, 20 s; 72°C, 10 s) and m cycles of full-COLD-PCR cycling (98°C, 10 s; 72°C, 30 s; T c , 10 s; 58°C, 20 s; 72°C, 10 s), such that m ϩ n ϭ 45, with a final melting curve from 65°C to 95°C.
HRM ANALYSIS WITH DMSO
A 10-L volume of each conventional PCR product or full-COLD-PCR product was transferred to a 96-well plate, and DMSO was added into each sample and mixed well to make a final concentration of 5%, 7%, or 10%. Finally, 20 L mineral oil was added to each well. We also evaluated each sample without adding DMSO for HRM on the same plate as a control sample. HRM was performed on a 96-well LightScanner ® system (Idaho Technology). The software sensitivity level was set at 1.2 for computing DNA variant groups. All experiments were replicated Ն3 independent times for assessing the reproducibility of the results.
DROPLET DIGITAL PCR FOR MUTATION ABUNDANCE VALIDATION
Droplet digital PCR (ddPCR) reactions were carried out as previously described (31 ) to verify the mutation abundance of cell line DNA samples. Sequences of primers and probes are shown in online Supplementary Table 1B. Amplifications were performed in a 20-L volume containing 1ϫ ddPCR Supermix for probes (Bio-Rad), 900 nmol/L forward and reverse primers (synthesized by Integrated DNA Technologies), 250 nmol/L 6-carboxyfluorescein (FAM) and hexachlorofluorescein (HEX) probes (Integrated DNA Technologies), and 10 ng genomic DNA or real-time PCR products (1-5 000 000 final dilution for conventional PCR or full-COLD-PCR products). Droplets were then generated with DG8™ droplet generator cartridges (Bio-Rad) which contain 20 L aqueous phase with 70 L droplet generation oil (Bio-Rad). Samples were transferred to a 96-well reaction plate and then sealed with the PX1 PCR plate sealer (Bio-Rad) for 10 s at 180°C before thermal cycling. The thermal cycling program was performed on an Eppendorf Mastercycler ep Gradient S (Eppendorf) with an initial denaturation step at 95°C for 10 min, followed by 40 cycles of 30-s denaturation at 94°C, 60-s annealing at 58°C, and a final step holding at 98°C for 10 min. Then the plate was transferred to a QX100 droplet reader (Bio-Rad) for endpoint reading. Calculation of absolute number of positive events for a given channel (FAM or HEX) and the ratio and the fractional abundance of mutations for each sample was performed with Quantasoft (Bio-Rad). The determination of number of target copies per droplet (number of copies of target molecule) was adjusted by the software to fit a Poisson distribution model with 95% confidence level.
SANGER SEQUENCING
The PCR products were digested by exonuclease I and shrimp alkaline phosphatase (New England Biolabs) and processed for Sanger sequencing at Eton Bioscience. To enable sequencing of short PCR amplicons, a 30-T tail was added to the 5Ј end of the forward primer (see online Supplementary Table 1B) .
Results
DMSO EFFECT ON IMPROVING HRM DETECTION SENSITIVITY
To examine the effect of DMSO on HRM scanning, we conducted conventional PCR of cell line DNA that contained 3 different mutations in TP53 exon 8, serially diluted into WT control DNA. The mutation abundances obtained by dilution were verified with ddPCR before amplification, as shown in Fig. 1 . Varying amounts of DMSO, 5%-10%, were then added to PCR products before HRM analysis. Compared with PCR-HRM scanning without DMSO, increasing DMSO concentrations to 5% and 7% improved mutation discrimination (Fig. 2) . DMSO at 7% enables discrimination of 3 different mutations down to 1% mutation abundance ( Fig. 2) and improves the detection sensitivity limits of conventional HRM analysis (approximately 3%-10% abundance) (9 ) . Increasing the DMSO concentration to 10% did not further improve HRM detection sensitivity, whereas it created more variations in the melting profiles (not shown). Accordingly, we used 7% DMSO for post-PCR products in HRM scanning for subsequent experiments.
We also assessed the comparative effect of DMSO when using saturating dye (LCGreen) vs nonsaturating dye (SYBR Green I) for HRM on the same TP53 exon 8 sequence. First, conventional PCR reactions were conducted for WT homozygote and 3 different mutant homozygotes and heterozygotes. PCR reactions with LCGreen or SYBR Green I were run side by side for comparison. Then 7% DMSO was added to PCR products before HRM scanning. Online Supplementary Fig.  1 shows that, consistent with Graziano et al. (16 ) , adding 7% DMSO increases the melting peak difference between WT and homozygous mutant with SYBR Green I. LCGreen has the same effect in the presence of DMSO; however, the thermodynamic destabilization caused by the mutation results in a significantly larger melting peak difference between mutant and WT compared with SYBR Green I. Next, we performed HRM after conventional PCR with LCGreen or SYBR Green I using serial dilutions to define the mutation detection limits. Three different cell line DNA samples containing TP53 exon 8 mutations were diluted into WT DNA to generate variable mutation abundances. After PCR, 7% DMSO was added to each sample, followed by HRM analysis. Online Supplementary Fig. 2 demonstrates that the addition of DMSO improved mutation detection sensitivity considerably in HRM with saturating dye LCGreen, whereas there was no clear improvement with the use of DMSO with SYBR Green I under nonsaturating conditions.
To examine whether sequences other than TP53 exon 8 display improved sensitivity with post-PCR addition of 7% DMSO, we diluted DNA with mutations in 5 additional genes, BRAF (B-Raf protooncogene, serine/ threonine kinase), FLT3 (fms-related tyrosine kinase 3), IDH1 [isocitrate dehydrogenase 1 (NADPϩ), soluble], NRAS [neuroblastoma RAS viral (v-ras) oncogene homolog], and JAK2 (Janus kinase 2), into WT DNA such that a 1% mutation abundance was obtained. Online Supplementary Fig. 3A demonstrates that in all but 1 gene this method was able to detect mutations down to a 1% mutation level. In the case of JAK2, the improvement was not identified as significant by the software. Finally, we examined whether addition of DMSO before PCR also allows the same improvement in detection sensitivity. Online Supplementary Fig. 3B indicates a similar level of HRM sensitivity with post-PCR addition of DMSO.
FULL-COLD-PCR OPTIMIZATION AND HRM ANALYSIS
Primer design. Two main steps are central to implementing full-COLD-PCR: (a) the cross-hybridization of template DNA strands to create heteroduplexes between mutated and WT DNA strands, by lowering the temperature after complete denaturation, and (b) a subsequent preferential denaturation step, during which the duplex strands potentially containing mismatches denature first, resulting in preferential amplification of mutant DNA (19 ) . The temperature for DNA strand crosshybridization should not allow primers to bind during this step. Accordingly, primer melting temperatures often have to be adjusted to avoid unwanted template replication during cross-hybridization. A control experiment to ensure that primers do not bind at the temperature used for cross-hybridization entails a separate, 2-stage conventional PCR. Online Supplementary  Fig. 4A shows that, at an annealing temperature of 72°C, the 2-stage conventional PCR generates no PCR product for any annealing time. Accordingly, this combination of temperature and primers is deemed appropriate for full-COLD-PCR, since primers may not bind the template during the cross-hybridization step.
Optimization of conventional PCR cycles before switching to full-COLD-PCR cycling.
When amplifying directly from genomic DNA, a set of conventional PCR cycles precedes full-COLD-PCR to build enough template for efficient Mutation-containing genomic DNA is amplified by conventional PCR or full-COLD-PCR, followed by HRM scanning. The enrichment effect before and after full-COLD-PCR is confirmed by ddPCR.
cross-hybridization (19 ) . DNA hybridization rate is proportional to its concentration; hence hybridization is faster when there are more DNA molecules in the solution. We conducted a series of PCR reactions on DNA samples containing 0.6% mutation c.841GϾC (p.D281H) in TP53 exon 8, with different combinations of n cycles of conventional PCR and m cycles of full-COLD PCR, while keeping the sum of n and m constant (45). The resulting mutation abundance was evaluated by applying ddPCR before and after reactions. Online Supplementary Fig. 4B shows the effect of n and m on the final mutation enrichment. When n is close to the PCR threshold value (Cq), the mutation enrichment is highest. A combination of 25 cycles of conventional PCR and 20 cycles of full-COLD-PCR was chosen for further work. Additionally, with other conditions remaining the same, extension of heteroduplex hybridizing time from 30 s to 2 min did not substantially improve enrichment efficiency (data not shown); therefore, 30 s was chosen for further work.
Optimal denaturation T c on 2 PCR machines.
Another major factor affecting mutation enrichment during full-COLD-PCR is the critical temperature to enable the preferential denaturation of the mismatched heteroduplexes. We applied a gradient of critical temperatures to examine the effect on mutation enrichment (see online Supplementary Fig. 4C ). The data show a substantial enrichment in a temperature window of approximately 0.8°C (89.1°C-89.9°C) for melting temperature (T m )-decreasing and T m -retaining mutations (SW480, p.R273H, c.818 GϾA, and HCC1008, p.R273H, c.841GϾC). The T mincreasing mutation (PFSK-1, p.C275G, c.823 TϾG) shows lower enrichment efficiency and a narrower T c window around 0.4°C (89.3°C-89.7°C). Therefore, we chose 89.5°C as a single T c for full-COLD-PCR cycling to ensure substantial enrichment for all possible mutations in TP53 exon 8. Finally, to test the differences in critical temperatures for full-COLD-PCR conducted on a different PCR machine, we performed the same test on a 96-well Bio-Rad CFX realtime PCR system. The same tendency among different mutation types was demonstrated (see online Supplementary Fig. 4D ), although the optimal tem- perature range shifted by 0.5°C to higher temperatures on Bio-Rad PCR relative to Cepheid SmartCycler. We chose 90.1°C as the critical temperature for full-COLD-PCR cycling on the Bio-Rad PCR system.
HRM IN THE PRESENCE OF POST-FULL-COLD-PCR DMSO
Under optimized conditions for full-COLD-PCR, we tested HRM mutation scanning with DNA containing 3 different TP53 exon 8 mutations serially diluted into WT DNA. Full-COLD-PCR increased HRM detection sensitivity for all 3 mutations down to 1%-2% mutation abundance (Fig. 3, A-C) . The mutation enrichment was confirmed via ddPCR (see online Supplementary Table 2 ). In the presence of 7% DMSO, full-COLD-PCR products showed improved detection sensitivity with HRM scanning for all 3 cell lines (Fig. 3, D-F) . Mutation abundances of 0.2%-0.3% were discriminated from WT DNA via HRM after full-COLD-PCR in the presence of 7% DMSO (see online Supplementary Fig. 5 ), producing an overall increase in HRM detection sensitivity by approxi- 
MUTATION SCREENING OF CLINICAL SAMPLES
We applied both conventional PCR-HRM and the optimized full-COLD-PCR-HRM protocol to 11 MDS samples with unknown mutation status, plus 3 lung tumor samples and 1 colorectal sample previously shown to contain TP53 exon 8 mutations at low abundance (23 ) . With conventional PCR-HRM without DMSO, only 1 sample (MDS sample SM-2DD63) was discriminated from WT samples (Fig. 4A) . When 7% DMSO was added during HRM, 2 more samples (MDS sample SM-2DD7X and colorectal sample CT20) were distinguished from WT samples (Fig. 4B) . Full-COLD-PCR-HRM with or without DMSO was able to identify mutations in 1 additional MDS sample (SM-2DD6R), plus all the lung tumor and colorectal samples that were previously confirmed to have mutations in TP53 exon 8 (Fig. 4, C  and D) . By performing Sanger sequencing on the full-COLD-PCR-amplified samples with mutations, the type and position of the mutations shown on HRM were identified. Sample SM-2DD63 showed a c.818 GϾA mutation and sample SM-2DD7X showed a c.844 CϾT mutation (see online Supplementary Fig. 6 ).
Discussion
Our data demonstrate that the detection limits in HRM analysis with saturating dyes, a commonly used process for mutation scanning in clinical and research applications, can be improved by simply adding DMSO. Under nonsaturating dye conditions (SYBR Green I), there is only marginal improvement. Conventional PCR followed by HRM with 7% DMSO was able to detect mutation abundance of approximately 1%, and if this was preceded by full-COLD-PCR, the detection sensitivity improved further and mutation abundances down to 0.2%-0.3% could be discriminated from WT. This improves the ability for detection of low-level mutations in clinical samples. Recent work has demonstrated that such mutations can have independent prognostic significance in MDS (27 ) , and detection of clonal as well as low-level mutations in hematologic malignancies is becoming clinically important (32, 33 ) . The intrinsic property of full-COLD-PCR for enriching multiple mutations in the target amplicons makes it a most suitable platform for closed-tube mutation scanning in combination with HRM. Full-COLD-PCR does not require a change in instrumentation and in most cases can retain the originally used PCR primers. However, the optimization workflow for selection of primers and critical denaturation temperatures described herein (see online Supplementary Fig. 4 , A and C) must be followed and established for each amplicon.
Addition of DMSO in conjunction with saturating dyes to improve HRM analysis can be performed either before or after PCR and can be applied to any platform on the basis of HRM detection. Among HRM applications, HRM genotyping (5 ) is more frequently used than HRM mutation scanning. Because the effect of DMSO on DNA duplex stability should be general, it may be possible that DMSO can also improve the detection sensitivity in HRM genotyping. It is also possible that organic solvents such as betaine and formamide that are used as PCR modifiers (14, 34 -37 ) may improve HRM analysis.
